Encelto™

Revakinagene taroretcel-lwey

People with a rare eye disease called MacTel may benefit from a newly approved cell therapy called revakinagene taroretcel-lwey (Encelto™), a cell-based gene therapy that slows the progression of the disease. The Duke Eye Center is among the few sites in the country offering this therapy, which received FDA approval in 2025.

About MacTel

MacTel (macular telangiectasia type 2) causes the slow degeneration or death of cells called photoreceptors in the retina, at the back of the eye. It leads to the loss of sharp, detailed vision, especially central vision, which can affect tasks like driving, reading, and recognizing faces.

Call for an Appointment

How Encelto Treats MacTel

The size of a grain of rice, the Encelto capsule contains more than 200,000 living cells within a permeable skin that slowly releases proteins that keep the photoreceptors healthy. It is embedded in your eye during a simple outpatient procedure. While Encelto can’t restore your vision, it can help preserve it for longer.

Find an Encelto™ Doctor
Matching Results
Filter Results
Filter by:
Use My Current Location
Located Near You
Loading Results
Showing of Doctors
Load More View All
×

What to Expect

During your first consultation, our retinal specialists will take your medical history and perform several exams to confirm your diagnosis and determine whether you would benefit from Encelto. If you are a candidate, you will meet with a financial counselor to help you navigate the health insurance process. You will also meet with a Duke anesthesiologist to clear you for surgery.

The surgery will take place at the Duke Eye Center. You’ll be given local anesthesia as well as an additional injection around the eye area to numb the area completely. Then the surgeon will insert the Encelto capsule. You will be able to go home after the surgery, and you will have follow-up appointments the next day, week, and month.

Your vision may be blurry and your eyes may be itchy for the first couple of days following the procedure, but these issues should resolve after the first week. Because MacTel usually affects both eyes, we will start the process for your other eye about a month following your first eye.

Our Locations

Duke Health offers locations throughout the Triangle. Find one near you.

Find a Location

Why Choose Duke

Experience With Encelto From the Ground Up

We’ve developed an expertise with Encelto that few centers can match. We were involved in the early phases of designing its clinical trials, and we were also part of the trials through our Reading Center.

Compassionate, Supportive Environment

We offer patient support services, including educational materials and programs, a low vision rehabilitation program, and a dedicated social worker to help you and your loved ones manage your eye disease and maximize your quality of life.

Sophisticated Retinal Imaging

Our researchers are national leaders in the use of sophisticated imaging technology and interpreting results. Our years of experience and extensive resources allow us to recommend the best treatment options. We are also one of the few centers in the U.S. to use OCT imaging in the operating room. This technology allows us to visualize the layers of the eye with greater detail and is used to more precisely guide treatment plans.

Best Eye Hospital in North Carolina

Where you receive your care matters. Duke University Hospital is proud of our team and the exceptional care they provide. They are why our ophthalmology program is ranked seventh in the nation and is the highest-ranked program in North Carolina, according to U.S. News & World Report for 2025–2026.

This page was medically reviewed on 02/27/2026 by
Support Duke Health research or honor a loved one with a tribute gift.